Highlights Bicycle Therapeutics plc

Equities

BCYC

US0887861088

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
24.2 ^USD	+3.20%		+6.75%	+33.85%

Apr. 29	European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading	MT
Apr. 26	European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading	Apr. 29	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%	Apr. 26	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	Apr. 19	MT
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading	Apr. 18	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	Apr. 04	MT
Q32 Bio Appoints Lee Kalowski as President	Apr. 03	CI
European Equities Traded in the US as American Depositary Receipts Flat in Tuesday Trading	Mar. 19	MT
Bicycle Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 20	CI
Bicycle Therapeutics plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 20	CI
Bicycle Therapeutics Provides Clinical Updates for BT8009, BT7480 and BT5528	Dec. 14	CI
Bicycle Therapeutics plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
Bicycle Therapeutics Says Investigational Therapy for Bladder Cancer BT8009 Selected for FDA Pilot Program	23-10-19	MT
Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer	23-09-11	CI
Bicycle Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03	CI
Bicycle Therapeutics, Bayer Launch Collaboration to Develop Radioconjugates for Oncology Targets	23-05-10	MT
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology	23-05-10	CI
Bicycle Therapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04	CI
Bicycle Therapeutics, Novartis Enter Drug Discovery Collaboration	23-03-28	MT
Bicycle Therapeutics Announces A Strategic Collaboration with Novartis to Discover, Develop and Commercialize Bicycle® Radio-Conjugates	23-03-28	CI
Physiomics wins further contract from Bicycle Therapeutics	23-03-10	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bicycle Therapeutics plc

Equities

BCYC

US0887861088

Highlights

Filters